Background & Aims A better understanding of prognostic factors within the heterogeneous
spectrum of pediatric Crohn's disease (CD) should improve patient management and reduce …

Big data methodologies, made possible with the increasing generation and availability of
digital data and enhanced analytical capabilities, have produced new insights to improve …

Background & Aims The Paris pediatric modification of the Montreal classification defines
very early onset inflammatory bowel disease (VEO-IBD) as a form of IBD distinct from that of …

The rate of pediatric inflammatory bowel disease (IBD) has been increasing over the last
decade and this increase has occurred most rapidly in the youngest children diagnosed< 6 …

Objectives: Inflammatory bowel disease [IBD] presenting in early childhood is extremely
rare. More recently, progress has been made to identify children with monogenic forms of …

Curcumin belongs to the family of natural compounds collectively called curcuminoids and it
possesses remarkable beneficial anti-oxidant, anti-inflammatory, anti-cancer, and …

Background & Aims A better understanding of prognostic factors in ulcerative colitis (UC)
could improve patient management and reduce complications. We aimed to identify …

Abstract Background and Aims: Very-early-onset inflammatory bowel disease [VEO-IBD] is a
form of IBD that is distinct from that of children with an older onset. We compared changes …

Inflammatory bowel disease (IBD), including Crohn disease and ulcerative colitis, is
characterized by chronic intestinal inflammation due to a complex interaction of genetic …

Objective To evaluate the presentation, therapeutic management, and long-term outcome of
children with very early-onset (VEO)(≤ 5 years of age) inflammatory bowel disease (IBD) …